John Dobak, M.D.
President and CEO
John Dobak, M.D., has served as the President, CEO and Board Member of DermTech, Inc. since 2012. DermTech is a leader in precision dermatology enabled by a non-invasive skin genomics platform. DermTech’s first product, the Pigmented Lesion Assay (“PLA”), is a breakthrough solution for a decades-old unmet medical need: enhanced early melanoma detection. Dr. Dobak has been involved in the formation of several entrepreneurial companies in San Diego over the last 20 years, including Pantherics, 10xBio, INNERCOOL Therapies and CryoGen/CryoCor. These companies have developed and/or marketed both drugs and therapeutic devices. Dr. Dobak and these companies are the recipients of several awards for entrepreneurship and innovation, including San Diego Business Journal CEO of the Year, UCSD Connect’s Most Innovative New Product and MIT’s TR 100. Dr. Dobak is a member of the San Diego YPO chapter. Dr. Dobak received a bachelor’s degree from UCLA and a medical doctorate from UCSD.